Provided by Tiger Trade Technology Pte. Ltd.

COSMOS HEALTH INC

0.2247
+0.00853.93%
Post-market: 0.2244-0.0003-0.13%19:48 EDT
Volume:3.77M
Turnover:863.42K
Market Cap:22.69M
PE:-0.36
High:0.2388
Open:0.2224
Low:0.2189
Close:0.2162
52wk High:1.32
52wk Low:0.1616
Shares:101.00M
Float Shares:78.78M
Volume Ratio:2.25
T/O Rate:4.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6204
EPS(LYR):-0.6321
ROE:-104.00%
ROA:-18.42%
PB:1.10
PE(LYR):-0.36

Loading ...

Cosmos Health Unit Signs 3-Year Manufacturing Deal With Verisfield

MT Newswires Live
·
Jun 11

Cosmos Health Signs 3-Year Contract Manufacturing Agreement With Verisfield for 3.9 Million Units of Vasclor Gest Progesterone Pessaries

THOMSON REUTERS
·
Jun 11

Cosmos Health unit Cana signs 3-year deal to make 3.9 million VASCLOR GEST progesterone pessaries for Verisfield

Reuters
·
Jun 11

Cosmos Health - Targets Over $200 Mln Revenue, $44.2 Mln Adj Ebitda, $92.3 Mln Equity by 2029

THOMSON REUTERS
·
Jun 10

Cosmos Health - Expects FY2026 Revenue to Surpass $90 Mln, up 38% Year-Over-Year

THOMSON REUTERS
·
Jun 10

Cosmos Health projects FY2029 revenue of $200.6 million, adjusted EBITDA $44.2 million

Reuters
·
Jun 10

Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway

GlobeNewswire
·
Jun 10

Cosmos Health unit wins contract manufacturing agreement with Provident Pharma

TIPRANKS
·
Jun 10

Cosmos Health unit Cana signs 5-year Provident deal to make 385,000 CERTORUN units

Reuters
·
Jun 10

Cosmos Health Inaugurates State-of-the-Art Capsule Production Line With New 5-Year Contract Manufacturing Agreement With Provident Pharmaceuticals for 385,000 Units of Certorun

THOMSON REUTERS
·
Jun 10

Cosmos Health unit acquires international patent application WO2025108566A1 from Cloudpharm

Reuters
·
Jun 08

Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives

THOMSON REUTERS
·
Jun 08

Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories

GlobeNewswire
·
Jun 05

Cosmos Health secures EU-wide distribution for Sky Premium Life via Skroutz

Reuters
·
Jun 05

Cosmos Health - Identifies $20 Mln in Non-Core Assets for Potential Monetization

THOMSON REUTERS
·
Jun 04

Cosmos Health explores monetizing about $20 million in non-core assets to fund acquisitions or cut debt

Reuters
·
Jun 04

Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value

GlobeNewswire
·
Jun 04

Cosmos Health says it sees no business reason for recent share price decline

Reuters
·
Jun 02

Cosmos Health Provides Balance Sheet Update: Highlights European Investment Bank Financing Discussions for up to €25M, Eliminates 38% of Warrant Overhang With No Dilution; Reaffirms Growth Trajectory; Notes No Known Business Reason for Recent Share Price Decline

THOMSON REUTERS
·
Jun 02

Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657

GlobeNewswire
·
Jun 01